Invention Grant
- Patent Title: Formulations of cycloserine compounds and applications thereof
-
Application No.: US16130747Application Date: 2018-09-13
-
Publication No.: US11291654B2Publication Date: 2022-04-05
- Inventor: Guochuan Emil Tsai , Ching-Cheng Wang , Hsin-Hsin Yang , Hsuan-Ang Tsai
- Applicant: SyneuRx International (Taiwan) Corp.
- Applicant Address: TW New Taipei
- Assignee: SyneuRx International (Taiwan) Corp.
- Current Assignee: SyneuRx International (Taiwan) Corp.
- Current Assignee Address: TW New Taipei
- Agency: McDermott Will & Emery LLP
- Main IPC: A61K31/42
- IPC: A61K31/42 ; A61K9/48 ; A61K9/20 ; A61K9/28 ; A23L33/10 ; A61P25/28 ; A61P25/24 ; A61P25/22 ; A61P25/18 ; A61P25/16 ; A61P31/06
Abstract:
Formulations comprising cycloserine compounds and one or more enteric materials in a solid dosage form, and uses thereof for treating and/or reducing the risk of a neuropsychiatric disorder or tuberculosis.
Public/Granted literature
- US20200085792A1 FORMULATIONS OF CYCLOSERINE COMPOUNDS AND APPLICATIONS THEREOF Public/Granted day:2020-03-19
Information query
